slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,387
Current window 12,481-12,510
Pages 3,680
Rows per page 30
Component
12,481-12,510 of 110,387
35
Page 35 of a larger document, containing extensive footnotes citing legal and journalistic sources.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
36
This is a text-heavy page from a report or legal document, likely an appendix or supporting evidence page.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
37
This is a page from a legal or investigative report, containing footnotes and legal citations.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
38
This is a page from a formal investigative report, likely a Congressional committee report.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
39
This is a page from a formal report or legal document, likely a congressional or investigative committee report.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
40
This appears to be a page from a formal investigative report or legal document.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
41
This appears to be a page from a formal investigative report or legal document, containing footnotes and an email excerpt.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
42
This appears to be a page from a formal investigative report or legal document, indicated by the footnote citations.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
43
This slide appears to be from a report or legal document detailing McKinsey's involvement with Purdue Pharma, specifically focusing on the 'ADF Strategy'.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
44
The slide contains a pull-quote highlighting the core strategy and detailed footnotes citing internal McKinsey documents and external reports.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
45
This slide appears to be a page from a formal report or legal document, containing narrative text and footnotes.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
46
This appears to be a page from a legal or investigative report (indicated by footnotes and redacted text).Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
47
This appears to be a page from a formal investigative report or legal document, given the footnote style and content.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
49
This appears to be a page from a formal report or legal document, indicated by the footnote numbering and page number at the bottom.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
50
This appears to be a page from a congressional or investigative report (page 50).Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
51
This page contains footnotes referencing specific internal documents (MCK-HCOR codes) and news articles.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
52
Page 52 of a report, likely a congressional or investigative document.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
02
The slide uses checkmarks and an X to distinguish between what the document provides and what it does not.Quantum Technology Monitor 2022 · McKinsey
Consulting deck Strategy consulting Beat · Attention1 hit
05
The slide uses a hub-and-spoke style diagram to represent the interconnected nature of the three quantum technology domains.Quantum Technology Monitor 2022 · McKinsey
Consulting deck Strategy consulting Beat · NeedLoop · Pattern Hunter1 hit
08
The slide uses a three-column layout with icons to summarize key market insights.Quantum Technology Monitor 2022 · McKinsey
Consulting deck Strategy consulting Beat · NeedLoop · Pattern Hunter1 hit
09
The slide uses a Venn-like diagram to represent the three sectors, though they are presented as distinct categories.Quantum Technology Monitor 2022 · McKinsey
Consulting deck Strategy consulting Beat · NeedLoop · Pattern Hunter1 hit
11
The chart uses a combination of solid and dashed lines to represent actual vs. estimated funding.Quantum Technology Monitor 2022 · McKinsey
Consulting deck Strategy consulting Beat · Satisfaction1 hit
12
The chart uses a line graph to visualize growth, with a dashed box highlighting the recent plateau/slowdown period.Quantum Technology Monitor 2022 · McKinsey
Consulting deck Strategy consulting Beat · Satisfaction1 hit
14
The table includes a legend for icons representing Quantum computing and Quantum communication, and footnotes explaining data limitations and specific deal contexts.Quantum Technology Monitor 2022 · McKinsey
Consulting deck Strategy consulting Beat · Satisfaction1 hit
16
The slide uses a bar chart for global funding and a pie chart for EU-specific funding distribution.Quantum Technology Monitor 2022 · McKinsey
Consulting deck Strategy consulting Beat · Satisfaction1 hit
17
The slide highlights that Quantum Computing (QC) receives the majority of US public funding compared to Quantum Communications (QComms) and Quantum Sensing (QS).Quantum Technology Monitor 2022 · McKinsey
Consulting deck Strategy consulting Beat · Satisfaction1 hit
18
McKinsey & Company slide 18Quantum Technology Monitor 2022 · McKinsey
Consulting deck Strategy consulting Beat · Satisfaction1 hit
20
The table includes a footnote regarding data transparency for China and Japan.Quantum Technology Monitor 2022 · McKinsey
Consulting deck Strategy consulting Beat · Satisfaction1 hit
21
The table is organized into three columns of country lists, each with 2021 and 2015 data points.Quantum Technology Monitor 2022 · McKinsey
Consulting deck Strategy consulting Beat · Satisfaction1 hit
22
The chart uses a waterfall-style layout to represent the distribution of companies across segments, with a total count at the end.Quantum Technology Monitor 2022 · McKinsey
Consulting deck Strategy consulting Beat · Satisfaction1 hit